Yanagimura, Naohiro
Takeuchi, Shinji http://orcid.org/0000-0002-3779-1454
Fukuda, Koji http://orcid.org/0000-0001-8544-6244
Arai, Sachiko
Tanimoto, Azusa
Nishiyama, Akihiro
Ogo, Naohisa
Takahashi, Hiroyuki
Asai, Akira
Watanabe, Satoshi
Kikuchi, Toshiaki
Yano, Seiji
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (20K08516, 19K16738, 19H03665)
Article History
Received: 18 June 2021
Accepted: 3 February 2022
First Online: 28 February 2022
Competing interests
: Seiji Yano has previously received commercial research grants from Yakult Honsha, Chugai Pharmaceutical, Boehringer-Ingelheim, and Novartis, and speaking honoraria from AstraZeneca, Chugai Pharmaceutical, Boehringer-Ingelheim, Novartis, and Pfizer. Seiji Yano is an Associate Editor for npj Precision Oncology. Akira Asai has previously received commercial research grants from Yakult Honsha. Hiroyuki Takahashi is an employee of Yakult Honsha Co., Ltd. No potential conflicts of interest are disclosed by the other authors.